Position/Title Scientific Director (Center for Biomedicine), Director (Parkinson-Clinic,

Central Hospital Bolzano), Professor

Address EURAC Center for Biomedicine, Via Galvani 31, 39100 Bolzano, Italy

Tel: +39-0471-055501; Fax: +39-0471-055599




1982-1990 Medical School (Innsbruck, Austria)

1990-1994 Neurology resident at the Department of Neurology, University of Verona, Italy

1993-1995 Subspeciality in Movement Disorders, Honorary Clinical Research Fellow with C. David Marsden, London, UK

2003 Habilitation (“Assistant Professorship”) in Neurology, University of Lübeck

2009 Associate Professor of Neurology (Professor), University of Lübeck

1996-present Staff Neurologist (1996-2001) and Director, Parkinson-Clinic, Department of Neurology, Central Hospital Bolzano, Italy

1996-2000 Director NEPT (Neuro-Epidemiology Project of South Tyrol)

2001-2003 Director, Research Program “GenNova: Applied Genomic Health Care Research in South Tyrol”, EURAC, Italy

2004-2010 Head, Institute of Genetic Medicine, EURAC, Italy

2010-present Scientific Director, Center for Biomedicine, EURAC, Italy



1998-present Member of the Scientific Advisory Board of the National Parkinson‘s Disease Federation (Parkinson-Italia), Roma, Italy

2008-present Member of the board of trustees of the SAKAM (South Tyrolean Academy for General Medicine), Bolzano, Italy

2010-present Member of the Executive Board of the LIMPE – DISMOV Academy (Accademia Italiana per lo Studio della Malattia di Parkinson e dei Disordini del Movimento)



1993 Training Fellowship from the “Unione Italiana Lotta alla Distrofia Muscolare (UILDM)”, Bolzano, Italy (stage at the National Hospital of Neurology and Neurosurgery, Queen Square, London, United Kingdom)

1994-1995: First awarded Research Fellowship of the Progressive Supranuclear Palsy (PSP) Europe Association, London, United Kingdom



From 248 original publications; total citations: 20,771; h-index: 69

  1. Hilker R, Klein C, Ghaemi M, …, Pramstaller PP. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001;49:367-376. (IF: 11.9)
  2. Pramstaller PP, Schlossmacher MG, Jacques TS, …, Klein C. Lewy body Parkinson disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 2005;58:411-422. (IF: 11.9)
  3. Pramstaller PP, Kis B, Eskelson C, …, Klein C. Phenotypic variability in a large kindred (Family LA) with deletions in the parkin gene. Mov Disord 2002;17:424-426. (IF: 5.6)
  4. Klein C, Djarmati A, Hedrich K, …, Pramstaller PP. PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism. Eur J Hum Genet 2005;13:1086-1093. (IF: 4.2)
  5. Volpato CB, De Grandi A, Buffone E, …, Pramstaller PP. 2q37 as a Susceptibility Locus for Idiopathic Basal Ganglia Calcification (IBGC) in a large South Tyrolean family. J Mol Neurosci 2009;39:346-353. (IF: 2.8)
  6. Sharma M, Ioannidis JP, Aasly JO, …, Pramstaller PP, …, Krüger R; GEO-PD Consortium. Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 2012;79:659-667. (IF: 8.3)
  7. Sharma M, Ioannidis JP, Aasly JO, …, Pramstaller PP, …, Krüger R; GEOPD consortium. A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet 2012;49:721-726. (IF: 5.7)
  8. Pichler I, Del Greco M F, Gögele M, …, Pramstaller PP, …, Minelli C. Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med 2013;10:e1001462. (IF: 14.0)
  9. Nalls MA, Pankratz N, Lill CM, …, GenePD, …, Singleton AB. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat Genet 2014;46:989-993. (IF: 29.4)
  10. Pattaro C, Gögele M, Mascalzoni D, … Pramstaller PP. The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results. J Transl Med 2015;13: 348. (IF: 3.9)